BPC-157 may be evaluated for localized injury concerns, while TB-500 may be considered for broader tissue support
Description Full Product Description (Epithalon 40mg) Epithalon 40mg is a synthetic peptide supplied by Zenith Supply Group , intended strictly for laboratory-based research applications
It has also been reported by Lim et al published in Cancer Research , that glutathione (GSH) deficiency is related to premature ovarian aging and even ovarian cancer
Tumor-targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Combining compounds can change effects, risks, and expectations
